With the help of single-cell microflorimetry, 45 Ca 2ϩ radiotracer fluxes, and patch-clamp in whole-cell configuration, we examined the effect of the amiloride derivative 3-amino-6-chloro-5-
drawbacks have limited its use. First, millimolar concentrations are required for its NCX inhibitory activity; second, it lacks specificity, for it can also inhibit both the ENaC at micromolar concentrations (Teiwes and Toto, 2007) and the Na ϩ /H ϩ exchanger (NHE) in the millimolar range. In the effort to develop amiloride derivatives provided with greater selectivity, Cragoe synthesized compounds more specific for NCX and NHE, respectively. In particular, two classes of amiloride analogs have been developed. The amiloride analogs of the first class, such as 5- [N-methyl-N-(guanidinocarbonylmethyl) ] amiloride, bear substituents on the 5-amino nitrogen atom of the pyrazine ring (Taglialatela et al., 1988) . They lack inhibitory properties on ENaC and NCX, even though they display greater effectiveness in inhibiting NHE in the 1 to 10 M range (Amoroso et al., 1990; Watano et al., 1996) . The compounds of the second class, having no inhibitory effect on the Na ϩ /H ϩ exchanger, bear substituents on the terminal guanidino nitrogen atom and behave as specific inhibitors (K i 1-10 M) of ENaC and NCX.
Among these compounds, CB-DMB seems to be the most specific inhibitor of NCX activity, because it has no inhibitory properties against NHE and the ENaC in excitable cells (Sharikabad et al., 1997) , such as neurons, in which the kidney ENaC are not expressed (Taglialatela et al., 1988 . On the other hand, during the past 10 years, the isothiourea derivative, KB-R7943, gained the reputation as a specific compound for inhibiting the antiporter and therefore as a probe to test the functional role of NCX . It has been reported that KB-R7943, at low micromolar concentrations, blocks the reverse mode operation of NCX, whereas high micromolar concentrations are needed to inhibit the forward mode (Iwamoto et al., 1996; Sobolevsky and Khodorov, 1999) . However, recent reports have obscured its reputation as a selective probe for NCX inhibition. In fact, several studies showed that KB-R7943 also exerts an inhibitory effect on several other pharmacological targets such as NHE, dihydropyridine-sensitive Ca 2ϩ uptake, passive Na ϩ uptake, Ca 2ϩ -ATPases, and Na ϩ ,K ϩ -ATPase and receptor-operated N-methyl-D-aspartate channels (Sobolevsky and Khodorov, 1999) . Recently, it was reported that the NCX inhibitor KB-R7943 activates large-conductance Ca 2ϩ -activated K ϩ channels in endothelial and vascular smooth muscle cells (Liang et al., 2008) . However, in the last decade several studies described CB-DMB as an effective probe to study the role of NCX in some pathophysiological mechanisms, including platelet hyperactivity in diabetes (Li et al., 2001) , collageninduced platelet activation (Li et al., 2001) , and in vitro and in vivo ischemic cell death mechanisms (Amoroso et al., 2000; Pignataro et al., 2004; Secondo et al., 2007; Tortiglione et al., 2007; Formisano et al., 2008) . Nevertheless, poor information is presently available about the effect of those compounds on each NCX isoform. In the present article, with the help of a more simple synthetic procedure that gives an increased yield and purification degree of CB-DMB, we investigated by means of patch-clamp technique, single-cell Fura-2 microfluorimetry, 45 Ca 2ϩ radiotracer fluxes, and deletion mutagenesis: 1) the specificity of CB-DMB on each of the three gene products NCX1, NCX2, and NCX3 in stably transfected baby hamster kidney (BHK) cells; 2) the selectivity of CB-DMB inhibition on the reverse and the forward modes of operation of NCX1, NCX2, and NCX3; 3) the molecular determinants of NCX molecule for CB-DMB action on each isoforms; 4) the possible interference of CB-DMB on other ionic channels such as voltage-dependent tetrodotoxin (TTX)-sensitive Na ϩ , L-type Ca 2ϩ , and ASIC1a currents.
Materials and Methods
Drugs and Chemicals. All chemicals used for the synthesis of CB-DMB were purchased from commercial sources.
Chemistry. The course of reactions and purity of products were controlled by TLC (silica gel 60F254s; Merck, Darmstadt, Germany) and spots were detected by UV radiation and exposition to iodine. Flash chromatography was performed on Merck silica gel (0.040 -0.063 mm). Melting points were determined with a Kofler hot-stage microscope (Leica VM HB Hotbench; Leica, Milan, Italy) and are uncorrected. Elemental analyses, indicated by the symbols of the elements, were within Ϯ 0.4% of theoretical values. Electrospray ionization mass spectra were recorded with an API 2000 liquid chromatography/tandem mass spectrometry system (Applied Biosystems, Foster City, CA). Proton and carbon-13 nuclear magnetic resonance (NMR) spectra were recorded on a Mercury 400 spectrometer (Varian, Inc., Palo Alto, CA) operating at 400 MHz. Chemical shift values are reported in ␦ units (ppm) relative to tetramethylsilane used as the internal standard.
Synthesis of N-(2,4-Dimethylbenzyl)guanidine (a). An aqueous solution of S-methylisothiourea hemisulfate salt (2.06 g; 14.8 mmol) was added to an ethanolic solution of 2,4-dimethylbenzylamine (2 g; 14.8 mmol). The mixture was refluxed for 2 h. After evaporation of ethanol, the title compound precipitated from water as sulfate salt. The solid was collected by filtration and dried. Under anhydrous conditions, Na (250 mg) was dissolved in dry methanol (20 ml) and the resulting solution was treated with dry N-(2,4-dimethylbenzyl)guanidine sulfate and stirred for 45 min. The Na 2 SO 4 formed was removed by filtration, and the methanolic solution was evaporated in a vacuum, yielding the title compound as a yellow solid (1.44 g; 55%); m.p. 74 to 75°C.
1 H NMR (CD 3 OD): ␦ 2.27, 2.28 (2s, 6H, -CH 3 ); 4.30 (s, 2H, -CH 2 ); 4.65 (br s, guanidine); 6.99 (d, 1H, 6-H); 7.03 (s, 1H, 3-H); 7.12 (d, 1H, 5-H);
13 C NMR (CD 3 OD): ␦ 22 and 24 (2CH 3 ); 47 (CH 2 ); 130.06 (C-6); 131.02 (C-5); 135 (C-3); 135.02 (C-4); 140 (C-2); 141.07 (C-1); 162 (C-guanidine). m/z:
Synthesis of Methyl 3-Amino-5-(4-chloro-benzyl)amino-6-chloropyrazine-2-carboxilate (b). A mixture of methyl 3,5-diamino-6-chloropyrazine-2-carboxylate (2 g; 9.86 mmol), 4-chlorobenzylbromide (3.04 g; 14.78 mmol), K 2 CO 3 (2.73 g; 19.7 mmol), and dry acetone (50 ml) was refluxed for 2 h. Evaporation of the solvent gave a residue that was taken up in ethyl acetate and washed with water. The organic layer was dried on Na 2 SO 4 , which was filtered and then evaporated in a vacuum. The obtained residue, which underwent flash chromatography by elution with CHCl 3 /n-hexane 9:1, yielded the title compound as a yellow solid (1.60 g; 50%); m.p. 144 to 145°C.
1 H NMR (DMSO-d 6 ): ␦ 3.85 (s, 3H, -OCH 3 ); 4.62 (s, 2H, -CH 2 ); 7.20 (s, 2H, 3-NH 2 ) 7.35, (m, 4H, 2Ј-H, 3Ј-H, 5Ј-H, 6Ј-H); 8.20 (s, 1H, 5-NH).
13 C NMR (DMSO-d 6 ): ␦ 43.7 (CH 2 ); 52 (OCH 3 ); 109.3 (C-2); 120.5 (C-6); 128.8 (C-5Ј and C-3Ј); 130.2 (C-2Ј and C-6Ј); 132.1 (C-4Ј); 138.4 (C-1Ј); 151.8 (C-5); 156 (C-3); 166.5 (CO (CH 2 Ј); 111 (C-2); 120.5 (C-6); 126.8 (C-3Љ); 127 (C-6Ј); 128 (C-5Ј); 128.8 (C-5Љ); 129.2 (C-6Љ); 131.1 (C-3Ј); 131.2 (C-2Љ); 132. (Invitrogen, Milan, Italy) supplemented with 5% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin (SigmaAldrich, St. Louis, MO). Pituitary GH 3 cells were obtained from Flow Laboratories (Irvine, Scotland) and grown on plastic dishes in Ham's F10 medium (Invitrogen) composed of 15% horse serum (Flow Laboratories), 2.5% fetal calf serum (Hyclone Laboratories, Logan, UT), 100 I.U. penicillin/ml, and 100 g streptomycin/ml. Human Embryonic Kidney (HEK293) cells were cultured in modified Eagle's medium with Earle's salts, supplemented with 10% fetal calf serum, nonessential amino acids, and glutamine. All the cells were cultured in a humidified 5% CO 2 atmosphere, and the culture medium was changed every 2 days. For microfluorimetric and electrophysiological studies, cells were seeded on glass coverslips (Thermo Fisher Scientific, Waltham, MA) coated with poly(L-lysine) (30 g/ml) (SigmaAldrich) and used at least 12 h after seeding.
Generation . In brief, BHK cells, grown on glass coverslips, were loaded with 6 M Fura-2 acetoxymethyl ester (Fura-2AM) for 30 min at 37°C in normal Krebs' solution containing the following: 5.5 mM KCl, 160 mM NaCl, 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPESNaOH, pH 7.4. At the end of the Fura-2AM-loading period, the coverslips were placed in a perfusion chamber (Medical Systems Corp., Greenvale, NY) mounted onto the stage of an inverted Axiovert 200 microscope (Carl Zeiss, Jena, Germany) equipped with a Fluar 40ϫ oil objective lens (Carl Zeiss). The experiments were conducted with a digital imaging system composed of MicroMax 512BFT cooled CCD camera (Princeton Instruments, Trenton, NJ), LAMBDA 10-2 filter wheeler (Sutter Instrument Company, Novato, CA), and Meta-Morph/MetaFluor Imaging System software (Universal Imaging, West Chester, PA). After loading, cells were alternatively illuminated at wavelengths of 340 nm and 380 nm by a Xenon lamp. The emitted light was passed through a 512-nm barrier filter. Fura-2 fluorescence intensity was measured every 3 s. Forty to sixty-five individual cells were selected and monitored simultaneously from each cover slip. All the results are presented as cytosolic Ca 2ϩ concentration. Assuming that the K D for Fura-2 was 224 nM, the equation of Grynkiewicz et al. (1985) was used for calibration. NCX activity, shown in Fig. 1 , was evaluated as Ca 2ϩ uptake through the reverse mode by switching the normal Krebs' medium to Na ϩ -deficient NMDG ϩ medium (Na ϩ -free): 5.5 mM KCl, 147 mM N-methylglucamine, 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES-NaOH, pH 7.4 (Secondo et al., 2007) . CB-DMB was incubated for 30 min before studying NCX activity. Efflux. 45 Ca 2ϩ influx into the cells was measured by the method described previously (Secondo et al., 2007) . After treatments, cells cultured in 24-well dishes were incubated in normal Krebs' medium: 
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5.5 mM KCl, 145 mM NaCl, 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES-NaOH, pH 7.4, containing 1 mM ouabain and 10 M monensin at 37°C for 10 min. Then, 45 Ca 2ϩ uptake was initiated by switching the normal Krebs' medium to Na ϩ -free NMDG: 5.5 mM KCl, 147 mM N-methyl-D-glucamine (NMDG), 1.2 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES-NaOH, pH 7.4, containing 10 M 45 Ca 2ϩ (74 kBq/ml) and 1 mM ouabain. After 30 s of incubation, cells were washed with an ice-cold solution containing 2 mM La 3ϩ to stop 45 Ca 2ϩ uptake. Cells were subsequently solubilized with 0.1 N NaOH and aliquots were taken to determine radioactivity and protein content (Bradford, 1976) .
To Cells were subsequently solubilized with 0.1 N NaOH, and aliquots were taken to determine radioactivity and protein content by the Bradford method (Bradford, 1976) . CB-DMB was incubated for 30 min before studying NCX activity.
Electrophysiology. NCX currents (I NCX ) was recorded from BHK wild-type (Wt) and BHK-NCX1, BHK-NCX2, and BHK-NCX3 stably transfected cells by patch-clamp technique in whole-cell configuration, as described previously . Currents were filtered at 5 kHz and digitized by use of a Digidata 1322A interface (Molecular Devices, Sunnyvale, CA). Data were acquired and analyzed by use of pClamp software (version 9.0, Molecular Devices). In brief, I NCX was recorded starting from a holding potential of Ϫ60 mV up to a short-step depolarization at ϩ60 mV (60 ms) (He et al., 2003) . Then, a descending voltage ramp from ϩ60 mV to Ϫ120 mV was applied. The current recorded in the descending portion of the ramp (from ϩ60 to Ϫ120 mV) was used to plot the current-voltage (I-V) relation curve. The magnitudes of I NCX were measured at the end of ϩ60 mV (reverse mode) and at the end of Ϫ120 mV (forward mode), respectively. The Ni 2ϩ -insensitive components were subtracted from total currents to isolate I NCX . External Ringer's solution contained 126 mM NaCl, 1.2 mM NaHPO 4 , 2.4 mM KCl, 2.4 mM CaCl 2 , 1.2 mM MgCl 2 , 10 mM glucose, 18 mM NaHCO 3 , 20 mM tetraethylammonium (TEA), 10 nM TTX, and 10 M nimodipine, pH 7.4. The dialyzing pipette solution contained 100 mM potassium gluconate, 10 mM TEA, 20 mM NaCl, 1 mM Mg-ATP, 0.1 mM CaCl 2 , 2 mM MgCl 2 , 0.75 mM EGTA, 10 mM HEPES, adjusted to pH 7.2 with CsOH. TEA (20 mM) and Cs were included to block delayed outward rectifier K ϩ components, nimodipine (10 M) and TTX (50 nM) were added to external solution to block L-type Ca channels and TTX-sensitive Na ϩ channels, respectively. I NCX values were normalized for membrane capacitance as reported previously . Ca 2ϩ current was recorded from pituitary GH 3 cells by the patchclamp technique in whole-cell configuration . Cells were perfused with an extracellular solution containing 10 mM BaCl 2 , 125 mM NaCl, 1 mM MgCl 2 , 10 mM HEPES, and 50 nM TTX, pH 7.3. The pipettes were filled with 110 mM CsCl, 10 mM TEA, 2 mM MgCl 2 , 10 mM EGTA, 8 mM glucose, 2 mM Mg-ATP, 0.25 mM cAMP, and 10 mM HEPES, pH 7.3. The Ba 2ϩ currents through Ca 2ϩ channels were obtained by subtracting the current elicited in the presence of 50 M CdSO 4 . Ba 2ϩ currents flowing through VDCC were activated by test pulses from Ϫ60 to 0 mV (100-ms duration) from holding of Ϫ60 mV, elicited at 0.066 Hz frequency (1 pulse every 15 s). The amplitude of the Ba 2ϩ currents was measured at the end of each depolarizing pulse.
For TTX-sensitive Na ϩ channel recordings, pituitary GH 3 cells were perfused with an extracellular Ringer's solution containing 20 mM TEA and 5 M nimodipine. The pipettes were filled with 110 mM CsCl, 10 mM TEA, 2 mM MgCl 2 , 10 mM EGTA, 8 mM glucose, 2 mM Mg-ATP, 0.25 mM cAMP, and 10 mM HEPES, pH 7.3. TTXsensitive Na ϩ currents were recorded by applying, from an holding potential of Ϫ70 mV, depolarizing voltage steps of 50-ms duration in 10 mV from Ϫ100 to ϩ 50 mV elicited at 0.066-Hz frequency (1 pulse every 15 s). The current-voltage relationship of Na ϩ currents were obtained normalizing the peak value for the membrane voltage imposed during the step.
ASIC1a currents were recorded with whole-cell patch-clamp technique as reported previously (Gunthorpe et al., 2001 ). The normal extracellular solutions contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM HEPES, pH 7.4, and pH was adjusted by use of NaOH or HCl. For solution with pH 6.0, 10 mM glycine and MES instead of HEPES were used for more reliable pH buffering. The pipettes were filled with 30 mM NaCl, 120 mM KCl, 2 mM MgCl 2 , 10 mM HEPES with 300 mOsm. A multibarrel perfusion system (SF-77B, Warner Instruments, Hamden, CT) was used for rapid exchange of solutions. Data were acquired by an Axopatch 200B amplifier and analyzed by use of the pClamp software (version 10.0, Molecular Devices). Traces were filtered at 5 kHz and digitized using a Digidata 1322A interface (Molecular Devices). To obtain the IC 50 of CB-DMB on each aforementioned current, all data were fitted to the following binding isotherm: y ϭ max/{1 ϩ (X/IC 50 )} n , where X is the drug concentration and n is the Hill coefficient.
Determination of Mitochondrial Activity. Mitochondrial dysfunction was evaluated with (3[4,5-dimethylthiazol-2-y1]-2,5-diphenyltetrazolium bromide, MTT) test (Holt et al., 1987; Amoroso et al., 1999) . In brief, after the experimental procedures, BHK-Wt, BHK-NCX1, BHK-NCX2, and BHK-NCX3 cells were washed with normal Krebs' solution and incubated with 1 ml of MTT solution (0.5 mg/ml in phosphate-buffered saline). This yellow water-soluble tetrazolium salt is converted into a water-insoluble purple formazan by the succinate dehydrogenase system of the active mitochondria. Therefore, the amount of formazan produced is proportional to the number of cells with mitochondria that are still vital. After 1 h of incubation at 37°C, cells were dissolved in 1 ml of DMSO, in which the rate of MTT reduction was measured by a spectrophotometer at a wavelength of 540 nm. Data are expressed as percentage of mitochondrial dysfunction versus sham-treated cultures.
Statistical Analysis. Data are expressed as mean (Ϯ S.E.M.). Statistical comparisons between controls and treated experimental groups were performed by use of the one-way analysis of variance, followed by Newman-Keuls test. P Ͻ 0.05 was considered statistically significant. (Secondo et al., 2007) . In particular, NCX activity was evaluated in the reverse mode of operation elicited by a single pulse of Na ϩ -deficient NMDG ϩ medium (Na ϩ -free) perfused in the presence of thapsigargin (1 M), a specific and irreversible inhib-
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؉ -Ca 2؉ Exchanger Isoforms 215 itor of the sarco(endo)plasmic reticulum (SERCA). In BHK-NCX1, BHK-NCX2, and BHK-NCX3, Na ϩ -free perfusion caused a rapid linear rise in [Ca 2ϩ ] i that was reduced by CB-DMB in a dose-dependent way (0.1-10 M) with the following IC 50 values: 286 nM for NCX1, 241 nM for NCX2, and 177 nM for NCX3 (Fig. 1) . As a matter of course, Na ϩ -free solution failed to produce a rise in [Ca 2ϩ ] i in wild-type BHK cells (BHK-Wt), which lacked all three NCX isoforms, whereas ionomycin (1 M) produced a rapid increase in [Ca 2ϩ ] i (Fig. 1 A) . The effect of CB-DMB on each modality of NCX transport was also determined in BHK-NCX1, BHK-NCX2, and BHK-NCX3 cells by means of radiotracer fluxes as Na 0 ϩ -dependent 45 Ca 2ϩ efflux and Na i ϩ -dependent 45 Ca 2ϩ uptake in the presence of different concentrations of the amiloride analog (0.1-10 M) (Fig. 2) . CB-DMB was able to reduce both the forward and the reverse modes of operation of NCX1, NCX2, and NCX3 in dose-dependent manner with the following IC 50 values: 550 nM for NCX1 forward, 390 nM for NCX1 reverse; 700 nM for NCX2 forward, 490 nM for NCX2 reverse; and 600 nM for NCX3 forward, 420 nM for NCX3 reverse.
The effect of CB-DMB on NCX1, NCX2, and NCX3 activity was assessed more directly by the patch-clamp technique in whole-cell configuration in stably transfected BHK cells. The whole-cell current was measured at ϩ60 mV and Ϫ120mV by use of the ramp-clamp protocol (see Materials and Methods). To isolate I NCX , cells were recorded for 5 min with the well known NCX inhibitor NiCl 2 (5 mM). The Ni 2ϩ -sensitive component, representing the isolated I NCX , was obtained as the difference between the Ni 2ϩ -sensitive and -insensitive components (Fig. 3 , B-G). No current corresponding to I NCX was recorded in BHK-Wt cells (Fig. 3A ) and no effect was detected after Ni 2ϩ application (Fig. 3A) . The incubation with CB-DMB (0.1-10 M) strongly inhibited both the outward (reverse mode) and inward (forward mode) direction of I NCX1 , I NCX2 , and I NCX3 in dose-dependent way with the following IC 50 values: 300 nM for NCX1 forward, 320 nM for NCX1 reverse; 300 nM for NCX2 forward, 250 nM for NCX2 reverse; and 260 nM for NCX3 forward, 230 nM for NCX3 reverse (Fig. 3) .
Effect of CB-DMB in NCX1, NCX2, and NCX3 Mutants Lacking "f-Loop" in Stably Transfected BHK Cells. To characterize the interaction of CB-DMB with the molecular structure of each NCX isoform, the intracellular "f-loop," a region mainly involved in the regulation of NCX function, has been mutated in NCX1, NCX2, and NCX3 genes by means of the deletion mutagenesis (see Materials and Methods). Specifically, the effect of the amiloride analog was investigated in NCX1 ⌬241-680, NCX2 ⌬263-668, and NCX3 ⌬292-708 mutants, whose activity, reported as percentage of the respective wild-type isoforms, was not significantly different from that of the corresponding wild-type isoforms (i.e., NCX1 ⌬241-680 111% Ϯ 10 versus NCX1 Wt; NCX2 ⌬263-668 98.5% Ϯ 8 versus NCX2 Wt; NCX3 ⌬292-708 92.4% Ϯ 12 versus NCX3 Wt). In these mutant cells, in which most of the hydrophilic domain of NCXs was deleted, both the Na ϩ -freeinduced rise in [Ca 2ϩ ] i and I NCX recorded in forward and reverse modes of operation were inhibited at the same extent by both 1 M and 10 M CB-DMB (Fig. 4, A and B) . This inhibition was lower if compared with the effect exerted by the drug on the activity of the wild type isoforms (Fig. 4, A  and B) , showing a decrease in the inhibitory efficacy of the amiloride derivative. On the other hand, the IC 50 values of CB-DMB evaluated in NCX1 ⌬241-680, NCX2 ⌬263-668, and NCX3 ⌬292-708 mutants did not significantly differ from those obtained in the corresponding wild-type isoforms (260 Ϯ 10 nM for NCX1 ⌬241-680, 400 Ϯ 15 nM for NCX2 ⌬263-668, and 350 Ϯ 18 nM for NCX3 ⌬292-708). Furthermore, deletion mutagenesis revealed that the substitution of Gly833 with cysteine in the ␣2 repeat of NCX1 did not prevent the inhibitory effect of CB-DMB either on Na ϩ -free induced [Ca 2ϩ ] i increase or on I NCX1 (Fig. 4, C and D) .
Effect of CB-DMB on L-Type VDCC in Pituitary GH 3
Cells. L-type VDCC activity was assessed in pituitary GH 3 cells by patch-clamp technique in whole-cell configuration by use of the test-pulse protocol (see Materials and Methods). Ltype VDCC activity was recorded for 5 min in control conditions and after the preincubation with CB-DMB (0.1, 1, and 10 M) (Fig. 5) . The peak inward Ba 2ϩ currents recorded after the treatment with the amiloride derivative was significantly inhibited compared with the respective controls. In these conditions, CB-DMB inhibited inward Ca 2ϩ currents in dose-dependent manner with an IC 50 of 2.8 M. The entity of L-type VDCC blockade induced by the inorganic Ca 2ϩ channel inhibitor Cd (50 M) was not significantly different from that produced by the highest concentration of CB-DMB (10 M) (Fig. 5) .
Effect of CB-DMB on TTX-Sensitive Na ؉ Currents in Pituitary GH 3 Cells. TTX-sensitive Na ϩ channel activity was assessed in GH 3 cells by patch-clamp technique in whole-cell configuration by use of the test-pulse protocol (see Materials and Methods). TTX-sensitive Na ϩ -channel activity was recorded in control conditions and after the preincubation with CB-DMB (0.1-10 M). In particular, the amiloride analog significantly inhibited TTX-sensitive Na ϩ currents in a dose-dependent manner (0.1-10 M) with an IC 50 of 1.6 M (Fig. 6 ). CB-DMB was able to induce a significant shift of Ϫ10 mV in Na ϩ -channel activation recorded from GH 3 cells (Fig. 6C) . Effect of CB-DMB on ASIC1a Activity in HEK293 Cells. ASIC1a activity was assessed by the patch-clamp technique in whole-cell configuration in HEK293 cells which constitutively expressed these pH-sensitive channels (see Materials and Methods). Cells were clamped at holding potential of Ϫ60 mV, and ASIC1a activity was recorded at pH 6 in control conditions and in the presence of CB-DMB (1, 3, and 10 M). Application of an acidic extracellular solution (pH 6) to HEK293 cells revealed the functional expression of an endogenous inward proton-gated current carried by ASIC1a channels (Fig. 7) . Even with maintained acidification, the proton-gated current was transient in nature, because of the rapid activation and subsequent inactivation of the current. If preicubated for 30 min, the amiloride analog significantly inhibited ASIC1a currents in a dose-dependent manner with an IC 50 of 2.4 M (Fig. 7) .
Effect of CB-DMB on Mitochondrial Viability in Stably Transfected BHK-NCX1, BHK-NCX2, and BHK-NCX3 Cells. To evaluate the mitochondrial function after 
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؉ -Ca 2؉ Exchanger Isoforms CB-DMB treatment, BHK-Wt-, BHK-NCX1-, BHK-NCX2-, and BHK-NCX3-transfected cells were exposed to different concentrations of CB-DBM (1, 10, and 15 M) (Fig. 8) . After 2 h of incubation with 1 and 10 M CB-DMB, the mitochondrial activity in these clones remained unaffected (Fig. 8) . At the concentration of 15 M only, the amiloride analog pro- duced a small, but significant, decrease in mitochondrial activity in all treated clones (Fig. 8) .
Discussion
The results of the present study showed that CB-DMB is a specific inhibitor of the three antiporter isoforms because it was able to reduce, in a dose-dependent manner, NCX1, NCX2, and NCX3 activity. The IC 50 values of CB-DMB, obtained by three different techniques, such as single-cell microfluorimetry, 45 Ca 2ϩ fluxes, and patch-clamp, for inhibiting NCX1, NCX2, and NCX3 isoforms, were similar and were in the nanomolar range of concentrations. In addition, the compound under study inhibited the forward and the reverse modes of operation of each isoform in the same range of nanomolar concentrations. In light of these pharmacological properties, CB-DMB can be considered a valid tool to inhibit, in those tissues that express all of the three NCX isoforms, the currents carried by the antiporter when it works in the forward or in the reverse mode of operation. The potency of CB-DMB is barely lower than that of the new isothiourea derivative YM-244769 which is the most potent available NCX1, NCX2, and NCX3 inhibitor working in the nanomolar range (Iwamoto and Kita, 2006) . However, YM-244769 inhibits NCX only in the reverse mode of operation, whereas CB-DMB inhibited NCX when it acts bidirectionally. On the other hand, the benzyloxy phenyl derivative SEA0400 bidirectionally inhibits NCX1 in the nanomolar range, reduces only mildly NCX2 activity, but it does not exert any effect on NCX3 activity. The other benzyloxy phenyl derivative SN6 inhibits NCX1, NCX2, and NCX3 isoforms only in the reverse mode of operation and in the micromolar range. The widely used reference standard for inhibiting NCX, KB-R7943 displays a lower potency than CB-DMB because it inhibits the two modes of operation of NCX1, NCX2, and NCX3 with IC 50 values in the micromolar range. The use of deletion mutagenesis showed that the intracellular f-loop of the NCX molecule, which is involved in the activity regulation of the antiporter, is a relevant molecular determinant for CB-DMB inhibitory action. In fact, the removal of the f-loop in NCX1, NCX2, and NCX3 proteins caused a partial loss of drug efficacy on each mutated isoform without interfering with its IC 50 values. Furthermore, this effect was more pronounced in the NCX1 mutants than in the NCX2 and NCX3 mutants. Because the lack of the f-loop did not completely remove the inhibitory action of CB-DMB, the existence of other molecular determinants that are relevant for CB-DMB effect can not be ruled out. However, the ␣2 repeat residue Gly833, a common molecular determinant required for other NCX1 blocker activity such as KB-R7943, SEA0400, and SN6 (Iwamoto, 2007) , did not seem to be involved in CB-DMB inhibitory action because its substitution with cysteine failed to prevent the inhibitory effect exerted by the amiloride analog. This suggests that the mechanism of CB-DMB action differs from the other known NCX blockers.
Because the amiloride derivatives may interfere with other ionic channels, we investigated the effects of CB-DMB on these plasma membrane proteins in excitable cells. This amiloride derivative in concentrations effective in inhibiting NCX1, NCX2, and NCX3 currents did not exert any effect on L-type VDCC, TTX-sensitive Na ϩ currents, and ASIC1a. However, it should be mentioned that when CB-DMB was used at micromolar concentrations, all of these voltage-and pH-sensitive channels were also inhibited by the amiloride analog. In fact, CB-DMB IC 50 values for each NCX isoform are lower than those observed for the other examined ionic channels. By contrast, other NCX inhibitors such as KB-R7943 and SEA0400, at concentrations inhibiting NCX currents, interfere with the activity of several receptors and ionic channels, including Na ϩ /H ϩ exchange, dihydropyridine-sensitive Ca 2ϩ uptake, passive Na ϩ uptake, Ca 2ϩ -ATPases and Na ϩ , K ϩ -ATPase Matsuda et al., 2005) , store-operated calcium channels (Arakawa et al., 2000) , TRPM3,5,6 (Kraft, 2007) , and receptoroperated N-methyl-D-aspartate channels (Sobolevsky and Khodorov, 1999) . In addition, it has been reported recently that KB-R7943 activates large-conductance Ca 2ϩ -activated K ϩ channels in endothelial and vascular smooth muscle cells (Liang et al., 2008) .
Collectively, the data of the present study showed that CB-DMB, when used in the nanomolar range, is one of the most potent compounds able to block the activity of the three NCX1, NCX2, and NCX3 isoforms when they work both in the forward and in the reverse modes of operation without interfering with other ionic channels. 
